These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26692100)
41. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102 [TBL] [Abstract][Full Text] [Related]
42. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
43. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma. Dai W; Miao H; Fang S; Fang T; Chen N; Li M Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282 [TBL] [Abstract][Full Text] [Related]
44. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma. Li WF; Ou Q; Dai H; Liu CA Int J Mol Sci; 2015 Aug; 16(8):19419-32. PubMed ID: 26287185 [TBL] [Abstract][Full Text] [Related]
45. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804 [TBL] [Abstract][Full Text] [Related]
46. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
48. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related]
49. Nuclear EpICD expression and its role in hepatocellular carcinoma. Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150 [TBL] [Abstract][Full Text] [Related]
50. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation. Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921 [TBL] [Abstract][Full Text] [Related]
51. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway. Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168 [TBL] [Abstract][Full Text] [Related]
52. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Fan Y; Xin XY; Chen BL; Ma X Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986 [TBL] [Abstract][Full Text] [Related]
53. Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition. Zhang WG; Li CF; Liu M; Chen XF; Shuai K; Kong X; Lv L; Mei ZC Cancer Lett; 2016 Aug; 378(2):111-9. PubMed ID: 27216981 [TBL] [Abstract][Full Text] [Related]
54. Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis. Lu C; He Y; Duan J; Yang Y; Zhong C; Zhang J; Liao W; Huang X; Zhu R; Li M Int J Oncol; 2017 Oct; 51(4):1135-1145. PubMed ID: 28902357 [TBL] [Abstract][Full Text] [Related]
55. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells. Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045 [TBL] [Abstract][Full Text] [Related]
56. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer. Yu L; Li X; Li H; Chen H; Liu H Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517 [TBL] [Abstract][Full Text] [Related]
57. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
58. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584 [TBL] [Abstract][Full Text] [Related]
59. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells. Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265 [TBL] [Abstract][Full Text] [Related]
60. Grp78 promotes the invasion of hepatocellular carcinoma. Su R; Li Z; Li H; Song H; Bao C; Wei J; Cheng L BMC Cancer; 2010 Jan; 10():20. PubMed ID: 20082722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]